FDA Drug recall D-1082-2019
Biotin 10 mg/mL Injection, 30 mL vial, Rx only, 511 S. Harbor Blvd., Building
- FDA Drug
- Class III
- terminated
- Published 2019-04-17
On 2019-04-17 the FDA classified a Class III recall of Biotin 10 mg/mL Injection, 30 mL vial, Rx only, 511 S. Harbor Blvd., Building by Auro Pharmacies, citing failed pH Specification: product does not meet pH label claim.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1082-2019 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2019-03-22 |
| Published | 2019-04-17 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Auro Pharmacies |
| Distribution | US |
Product
Biotin 10 mg/mL Injection, 30 mL vial, Rx only, 511 S. Harbor Blvd., Building. F, La Habra, CA 90631, 562-352-9630.
Reason
Failed pH Specification: product does not meet pH label claim.
Identifiers
| code_info | Lot 190205@1, expiry 08/4/19 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1082-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.